OL
EW icon

Optas LLC’s Edwards Lifesciences EW Stock Holding History

Optas LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Buy
+2,265
New +$190K 0.03% 453
2025
Q4 		– Sell
-3,284
Closed -$255K – 479
2025
Q3 		$255K Buy
+3,284
New +$257K 0.04% 301

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Optas LLC's EW Position: Q2 2026 in Review

Optas LLC opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,265 shares worth $205K. The stake represents 0.03% of the portfolio and ranks #453 among its holdings. This is a return to the name: Optas LLC previously reported a position in EW as recently as Q3 2025.

Optas LLC first reported a position in EW in Q3 2025 and has held it in 2 quarters since. The position peaked at $255K in Q3 2025. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Optas LLC held 2,265 shares of Edwards Lifesciences worth $205K as of Q2 2026.
  • Edwards Lifesciences was a new Optas LLC position in Q2 2026.
  • Edwards Lifesciences made up 0.03% of Optas LLC's portfolio in Q2 2026, its #453 holding.
  • Optas LLC first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 2 quarters since.
  • Optas LLC's Edwards Lifesciences position peaked at $255K in Q3 2025.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.